Table 5 Docking score of the designed Benzimidazole Derivatives.

From: Molecular docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis

Comp. Code

R

Rmsd/ub

Rmsd/lb

Docking score (kcal/mol)

P1

CH2CH3

0

0

 − 8.2

P2

CH2CH2CH2CH3

0

0

 − 6.9

P3

CH2CH2CH3

0

0

 − 6.8

P4

CH2COOH

0

0

 − 8.5

P5

2–OHC6H4

0

0

 − 8.2

P6

CH2CH2COOH

0

0

 − 7.3

P7

3–OHC6H4

0

0

 − 7.4

P8

4–OHC6H4

0

0

 − 8.0

P9

2,3–OHC6H3

0

0

 − 9.4

P10

2,4–OHC6H3

0

0

 − 7.9

P11

2,5–OHC6H3

0

0

 − 8.6

P12

2,6–OHC6H3

0

0

 − 9.0

P13

3,4–OHC6H3

0

0

 − 8.1

P14

3,5–OHC6H3

0

0

 − 8.8

P15

3–ClC6H4

0

0

 − 7.8

P16

2–CH3C6H4

0

0

 − 8.4

P17

2–COOHC6H4

0

0

 − 7.4

P18

2–NH2C6H4

0

0

 − 7.9

P19

3–NO2C6H4

0

0

 − 8.3

P20

2–COOHC6H4

0

0

 − 9.0

P21

3–BrC6H4

0

0

 − 8.0

P22

4–BrC6H4

0

0

 − 8.3

P23

4–CH2BrC6H4

0

0

 − 8.1

P24

4–NO2C6H4

0

0

 − 8.2

P25

3,4,5–OHC6H2

0

0

 − 7.8

P26

CH=CH–C6H5

0

0

 − 7.5

P27

6–NO2C6H4

0

0

 − 8.6

P28

4–CH3C6H4

0

0

 − 8.1

P29

2–NH2–3–OH–C6H3

0

0

 − 7.2

P30

CH=CH–3,4,5–OHC6H3

0

0

 − 8.6

P31

CH=CH–4–OHC6H4

0

0

 − 7.7

P32

2–OCOCH3C6H4

0

0

 − 9.6

P33

2–OH–3–CH3C6H3

0

0

 − 7.8

P34

2–OH–5–SO3HC6H3

0

0

 − 8.6

P35

3–CH3–4–NO2C6H3

0

0

 − 7.8

P36

4–CH3–6–NO2C6H3

0

0

 − 7.8

P37

CH3CHOH

0

0

 − 7.9

P38

2,5–OHC6H3

0

0

 − 8.9

P39

3–OCH3–4–OHC6H3

0

0

 − 7.8

P40

4–OCH3C6H4

0

0

 − 8.3

P41

COCH3

0

0

 − 7.4

P42

CH2–CHOH–COOH

0

0

 − 7.7

P43

Pyridine

0

0

 − 7.6

P44

CH=CH–COOH

0

0

 − 8.1

P45

CH=CH2

0

0

 − 7.6

P46

(CH2OH)5

0

0

 − 8.3

P47

COOH

0

0

 − 7.1

P48

(CH2)3COOH

0

0

 − 7.9

P49

(CH2OH)2COOH

0

0

 − 8.3

P50

CH2NHCOC6H5

0

0

 − 9.0

PAS

0

0

 − 4.7

Isoniazid

0

0

 − 5.5